Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Analysis By Treatment Type (Prophylactic Treatment, Rescue Treatment), By Drug Class (5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids, Benzodiazepines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Patient Demographics (Adults, Pediatrics), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: June 2024
- Report ID: 84417
- Number of Pages: 301
- Format:
-
keyboard_arrow_up
-
-
- Heron Therapeutics Inc.
- TESARO (a GSK company)
- Helsinn Healthcare SA
- Merck & Co. Inc.
- Amgen Inc.
- Fresenius Kabi AG
- Mylan N.V.
- Baxter International Inc.
- Kyowa Kirin Co. Ltd.
- CinnaGen Co.
- settingsSettings
Our Clients
- 84417
- June 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
